Search results for the GEO ID: GSE23882
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM587817
GPL570
Control_MFP_24hr_rep1 Control stable cells, mifepristone (5 nM) treatment, 24 hr cell line: colon cancer cell line HCT116 clone: Control stable clone agent: mifepristone dose: 5 nM time: 24 hr cells: Inducible control stable clone established from HCT116 colon cancer cells using the GeneSwitch system. stably integrated plasmids: pSwitch (Invitrogen, Carlsbad, CA, USA), pGene/V5 (Invitrogen) inducible protein: None. inducer: mifepristone (5 nM), 24 hr
GSM587818
GPL570
Control_MFP_24hr_rep2 Control stable cells, mifepristone (5 nM) treatment, 24 hr. cell line: colon cancer cell line HCT116 clone: Control stable clone agent: mifepristone dose: 5 nM time: 24 hr cells: Inducible control stable clone established from HCT116 colon cancer cells using the GeneSwitch system. stably integrated plasmids: pSwitch (Invitrogen, Carlsbad, CA, USA), pGene/V5 (Invitrogen) inducible protein: None. inducer: mifepristone (5 nM), 24 hr
GSM587819
GPL570
Control_MFP_24hr_rep3 Control stable cells, mifepristone (5 nM) treatment, 24 hr. cell line: colon cancer cell line HCT116 clone: Control stable clone agent: mifepristone dose: 5 nM time: 24 hr cells: Inducible control stable clone established from HCT116 colon cancer cells using the GeneSwitch system. stably integrated plasmids: pSwitch (Invitrogen, Carlsbad, CA, USA), pGene/V5 (Invitrogen) inducible protein: None. inducer: mifepristone (5 nM), 24 hr
GSM587820
GPL570
TIG1A_MFP_24hr_rep1 TIG1A stable cells, mifepristone (5 nM) treatment, 24 hr. cell line: colon cancer cell line HCT116 clone: TIG1A stable clone agent: mifepristone dose: 5 nM time: 24 hr cells: Inducible TIG1A stable clone established from HCT116 colon cancer cells using the GeneSwitch system. stably integrated plasmids: pSwitch (Invitrogen, Carlsbad, CA, USA), inducible TIG1A expression plasmid (pTIG1A-V5). inducible protein: Recombinant TIG1A (RARRES1) isoform containing 294 amino acids of TIG1A fragment at the N-terminus and Myc and His tags at the C-terminus. inducer: mifepristone (5 nM), 24 hr
GSM587821
GPL570
TIG1A_MFP_24hr_rep2 TIG1A stable cells, mifepristone (5 nM) treatment, 24 hr. cell line: colon cancer cell line HCT116 clone: TIG1A stable clone agent: mifepristone dose: 5 nM time: 24 hr cells: Inducible TIG1A stable clone established from HCT116 colon cancer cells using the GeneSwitch system. stably integrated plasmids: pSwitch (Invitrogen, Carlsbad, CA, USA), inducible TIG1A expression plasmid (pTIG1A-V5). inducible protein: Recombinant TIG1A (RARRES1) isoform containing 294 amino acids of TIG1A fragment at the N-terminus and Myc and His tags at the C-terminus. inducer: mifepristone (5 nM), 24 hr
GSM587822
GPL570
TIG1A_MFP_24hr_rep3 TIG1A stable cells, mifepristone (5 nM) treatment, 24 hr. cell line: colon cancer cell line HCT116 clone: TIG1A stable clone agent: mifepristone dose: 5 nM time: 24 hr cells: Inducible TIG1A stable clone established from HCT116 colon cancer cells using the GeneSwitch system. stably integrated plasmids: pSwitch (Invitrogen, Carlsbad, CA, USA), inducible TIG1A expression plasmid (pTIG1A-V5). inducible protein: Recombinant TIG1A (RARRES1) isoform containing 294 amino acids of TIG1A fragment at the N-terminus and Myc and His tags at the C-terminus. inducer: mifepristone (5 nM), 24 hr
GSM587823
GPL570
TIG1B_MFP_24hr_rep1 TIG1B stable cells, mifepristone (5 nM) treatment, 24 hr. cell line: colon cancer cell line HCT116 clone: TIG1B stable clone agent: mifepristone dose: 5 nM time: 24 hr cells: Inducible TIG1B stable clone established from HCT116 colon cancer cells using the GeneSwitch system. stably integrated plasmids: pSwitch (Invitrogen, Carlsbad, CA, USA), inducible TIG1B expression plasmid (pTIG1B-V5). inducible protein: Recombinant TIG1B (RARRES1) Isoform containing 228 amino acids of TIG1B fragment at the N-terminus and Myc and His tags at the C-terminus. inducer: mifepristone (5 nM), 24 hr
GSM587824
GPL570
TIG1B_MFP_24hr_rep2 TIG1B stable cells, mifepristone (5 nM) treatment, 24 hr. cell line: colon cancer cell line HCT116 clone: TIG1B stable clone agent: mifepristone dose: 5 nM time: 24 hr cells: Inducible TIG1B stable clone established from HCT116 colon cancer cells using the GeneSwitch system. stably integrated plasmids: pSwitch (Invitrogen, Carlsbad, CA, USA), inducible TIG1B expression plasmid (pTIG1B-V5). inducible protein: Recombinant TIG1B (RARRES1) Isoform containing 228 amino acids of TIG1B fragment at the N-terminus and Myc and His tags at the C-terminus. inducer: mifepristone (5 nM), 24 hr
GSM587825
GPL570
TIG1B_MFP_24hr_rep3 TIG1B stable cells, mifepristone (5 nM) treatment, 24 hr. cell line: colon cancer cell line HCT116 clone: TIG1B stable clone agent: mifepristone dose: 5 nM time: 24 hr cells: Inducible TIG1B stable clone established from HCT116 colon cancer cells using the GeneSwitch system. stably integrated plasmids: pSwitch (Invitrogen, Carlsbad, CA, USA), inducible TIG1B expression plasmid (pTIG1B-V5). inducible protein: Recombinant TIG1B (RARRES1) Isoform containing 228 amino acids of TIG1B fragment at the N-terminus and Myc and His tags at the C-terminus. inducer: mifepristone (5 nM), 24 hr
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes